ARTICLE

FindCenter AddIcon

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

By Maureen Meehan — 2017

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Read on hightimes.com

FindCenter Post-Image

The Drama of the Gifted Child: Part 2

Childhood trauma has an effect on adult mental illness

FindCenter AddIcon

EXPLORE TOPIC

MDMA